monthly income and residential status. Source of drinking water was also taken in account to find out a possible source of transmission. Every case was initially evaluated on the basis of history, clinical examination, liver function profile, and serological test of hepatitis E. The blood samples were screened using commercially available ELISA kits for markers of hepatitis E (EIAgen HEV IgM, Adaltis).These ELISA kit had a sensitivity of 100% and specificity of ≥ 99.5%. Serum bilirubin was measured using colorimetric method DMSO (Chronolab). ALT estimation was done by UV-Kinetic (IFCC) method (Chronolab). Prothrombin time was measured using Neoplastine CI Plus (rabbit brain thromboplastine) reagent in an automated instrument which used an optical detection. Consent was taken in each case and ethical clearance was sought from proper authority. Data were collected in a preformed questionnaire and face-to-face interview was carried out. Data were analyzed in SPSS 15.
Result:
Most of the patients (64%) were in third trimester and remaining 36% were in second trimester. Only 42% cases got boiled water; remaining 58% used to drink unpurified water from different sources. Most of them were house wife (76%); 63% came from urban areas and remaining from slum, rural or semi urban areas. Forty six percent patients had a monthly income less than five thousand taka. All of the patients presented with different prodromal symptoms, 27% complaint right upper abdominal pain. Acute hepatic failure (AHF) was detected in 56% pregnant women. In this study, the death rate of Hepatitis E in pregnancy was 43 %. (Fig II) 
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Biochemical Evaluation and Out Come of Hepatitis E in Pregnancy
Discussion:
HEV is transmitted by faeco-oral route. Major outbreaks of HEV are related with contaminated water or food supplies.
Epidemics of hepatitis E have been reported in Central and
South-East Asia, North and West Africa, and in Mexico, especially where faecal contamination of drinking water is common. Occasionally, FHF develops, with overall patient population mortality rates ranging between 0.5% -4.0%. 5 But a significant proportion of pregnant women can progress to fulminant hepatitis particularly in the third trimester, with a mortality rate varying from 30 to 100%.
6-14 A significant geographical distribution of FHF and fatal outcome in pregnancy with HEV was detected. Reports from Egypt, Europe and the USA have shown that the course and severity of viral hepatitis during pregnancy is not different from that in non-pregnant women. More studies are awaited to reveal this strange cause. The high mortality rate in pregnancy has been thought to be secondary to the associated hormonal (oestrogen and progesterone) changes during pregnancy and consequent immunological changes. 15 In this study, 64% women were in third trimester of pregnancy and remaining 36% were in second trimester. A study in Ghana found that HEV detected in women in their third trimester of pregnancy (80%) was significantly higher than in women in their second trimester of pregnancy (20%). Total 45 pregnant women with HEV were described in that study. 16 Another study conducted in Kashmir, India revealed the rate of HEV in pregnancy was 8.8%, 19.4% and 18.6% in first trimester, second trimester and third trimester respectively. 17 In this country, many women worked in densely populated unhygienic environment with very poor sanitation facilities. In this study, most of the pregnant women (58%) used to drink unpurified water from different sources and 76% were involved in house bound activities. Most of the women included in this study came from a very poor socio-economic background living in crowded urban, semiurban and slum areas. The study in Ghana previously mentioned also revealed a similar scenario where 93% of the pregnant women live and work in areas where the facilities for sanitation and water supply were inadequate. 16 This study revealed that all pregnant women had clinically detectable jaundice, 51% had temperature ≥ 99º F and 38% had palpable liver. Extensor plantar reflex was present in 55% cases and 27% had flapping tremor. Acute hepatic failure was detected in 56% pregnant women. A study was conducted in Guangdong Province, China among pregnant women with FHF revealed 100% patients were icteric, 24% had fever and features of AHF was detected in 76% cases. 18 Another study in Mumbai, India detected AHF in 30.7% pregnancy with hepatitis E. 19 A large prospective study from Northern India found that AHF was more common among HEV-infected pregnant women (55%) and this finding was quite similar to our study. 15 In this study, the mean value of serum bilirubin, ALT and PT was 11.62 mg/dl ± 8.01 SD, 777.75 U/L ± 590.39 SD and 29.88 sec ± 12.54 SD respectively. Biochemical evaluation was observed in the study conducted in Mumbai previously mentioned and found that the mean value of serum bilirubin, ALT and PT was 12 mg/dl, 882 U/L and 24 sec respectively among dead pregnant women with AHF due to HEV and these values were 11.5 mg/dl, 420 U/L and 8 sec respectively among surviving pregnant women. 19 Study conducted in Guangdong Province found the level of serum bilirubin, ALT and PT was 403.11±162.32 μmol/L (23.57 mg/dl), 424.05±285.12 U/L and 43.93±43.66 sec respectively. 18 Wide and variable death rate was observed in pregnancy with HEV in different studies. In this study, the death rate was 43%. A previously mentioned study from Northern India found a similar data (41%). 15 Slightly higher death rate (54%) was observed in the study conducted among AHF cases in Mumbai.
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Conclusion: There is no current recommendation for termination of pregnancy with HEV in AHF. Hemodynamic instability, hemostatic defects in a critically ill AHF patient discourages the surgery. Provision of safe drinking water and proper disposal of sanitary waste as well as better personal hygiene can ensure a HEV free safe pregnancy.
